Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Beauty Press Releases.
Press releases published on May 13, 2025
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights
GlobeNewswire
·
May 13, 2025
Progress continues in Phase 3 Orbit study of setrusumab in osteogenesis imperfecta (OI) Cash of $62.5 million as of March 31, 2025, expected to fund operations into 2027 LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“ …
First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study
GlobeNewswire
·
May 13, 2025
- ATTRibute-CM, BridgeBio’s Phase 3 clinical trial of acoramidis in patients with ATTR-CM, achieved statistical significance in reducing the risk of ACM or first CVH versus placebo in ATTRv-CM patients (59.1% risk reduction), establishing the mechanistic …
Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference
GlobeNewswire
·
May 13, 2025
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, …
Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program
GlobeNewswire
·
May 13, 2025
Reiterates Planned Submission of an NDA for Cytisinicline to FDA in June 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, May 13, 2025 SEATTLE and VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. …
Command Alkon’s Batch AI Honored as a 2025 Concrete Contractor Top Products Award Winner
GlobeNewswire
·
May 13, 2025
BIRMINGHAM, Ala., May 13, 2025 (GLOBE NEWSWIRE) -- Concrete Contractor, the nationally recognized magazine serving concrete construction professionals, names Command Alkon’s Batch AI a 2025 Concrete Contractor Top Products award winner. The 2025 Concrete …
Y-mAbs to Host Virtual Radiopharmaceutical R&D Update on May 28, 2025
GlobeNewswire
·
May 13, 2025
PRINCETON, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody- …
Invivyd to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
GlobeNewswire
·
May 13, 2025
WALTHAM, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on Tuesday, May 20, 2025, at 11:00 a.m. ET in …
atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder
GlobeNewswire
·
May 13, 2025
- In a Phase 1 study, EMP-01 (oral R-MDMA) demonstrated a unique, dose-dependent subjective effect profile that was generally found to be more similar to classical psychedelics than to racemic MDMA - The exploratory, randomized, double-blind, placebo- …
Altimmune Secures Up to $100 Million in Credit Facility from Hercules Capital
GlobeNewswire
·
May 13, 2025
GAITHERSBURG, Md., May 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that it has entered into …
Altimmune Announces First Quarter 2025 Financial Results and Business Update
GlobeNewswire
·
May 13, 2025
Top-line data from IMPACT Phase 2b trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH) expected in Q2 2025 Phase 2 trials in Alcohol Use Disorder (AUD) and Alcohol Liver Disease (ALD), expected to initiate in Q2 and Q3 2025, …
Acumen Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 13, 2025
Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026 Cash, cash equivalents and marketable securities of $197.9 million as of March 31, 2025, …
Best No-Drill Blinds (2025): SelectBlinds Awarded Top Tool-Free Shades by Expert Consumers
GlobeNewswire
·
May 13, 2025
Boston, May 13, 2025 (GLOBE NEWSWIRE) -- SelectBlinds has been recognized as a top provider in the growing no-drill blinds category by Expert Consumers. With increased demand for quick-installation window solutions that do not require hardware or damage to …
Y-mAbs Reports First Quarter 2025 Financial Results and Recent Corporate Developments
GlobeNewswire
·
May 13, 2025
Reported Net Product Revenues of $20.9 million for the first quarter of 2025, a year-over-year increase of approximately 8% National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Neuroblastoma updated to include …
Sotherly Hotels Inc. Reports Financial Results for the First Quarter Ended March 31, 2025
GlobeNewswire
·
May 13, 2025
WILLIAMSBURG, Va., May 13, 2025 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO), (“Sotherly” or the “Company”), a self-managed and self-administered lodging real estate investment trust (a “REIT”), today reported its consolidated results for the …
Jitterbit Harmony Platform Wins Silver Stevie® Award for Platform as a Service
GlobeNewswire
·
May 13, 2025
ALAMEDA, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced it has been awarded the Silver Stevie® Award in the ‘Platform as a Service’ category at the 23rd …
Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 13, 2025
~ Achieved First Quarter 2025 Total Net Revenues of $8.8 Million, Up 18% Year Over Year ~ ~ Positive Momentum from Company’s Refined, Targeted Sales Strategy and Enhanced Patient Support Services ~ ~ PEDMARQSI Now Commercially Available in Germany and the …
Wuffes on the Future of Dog Health: Trends, Innovation, and What’s Next Reported by Expert Consumers
GlobeNewswire
·
May 13, 2025
NEW YORK CITY, May 13, 2025 (GLOBE NEWSWIRE) -- As demand for evidence-based pet care continues to rise, Expert Consumers sat down with Wuffes co-founders Josh Savinson and Sam Venning to discuss what lies ahead for the dog health industry. The …
Crestline Hotels & Resorts Assumes Management of the Fairfield Inn & Suites New Orleans Downtown/French Quarter Area
GlobeNewswire
·
May 13, 2025
FAIRFAX, Va., May 13, 2025 (GLOBE NEWSWIRE) -- Crestline Hotels …
Best Dog Care Brand (2025): Wuffes Awarded Top Pet Wellness Company by Expert Consumers
GlobeNewswire
·
May 13, 2025
NEW YORK CITY, May 13, 2025 (GLOBE NEWSWIRE) -- Expert Consumers has recognized Wuffes as the Best Dog Care Brand of 2025, honoring the company for its data-driven approach, commitment to scientific integrity, and its impact on advancing the field of pet …
Best Security Software (2025): ESET Awarded Top Protection Suite by Expert Consumers
GlobeNewswire
·
May 13, 2025
NEW YORK CITY, May 13, 2025 (GLOBE NEWSWIRE) -- As the landscape of digital threats continues to evolve, the demand for robust, efficient, and user-friendly cybersecurity solutions has never been more pressing. Reflecting this shift, Expert Consumers has …